Last November, VC firm Thoma Brava closed an investment in open source Java specialist Azul, becoming its leading backer. Shortly afterwards Azul announced its first ...
Adoptive cell therapy (ACT) is a treatment that uses a cancer patient's own T lymphocytes with anti-tumour activity, expanded in vitro and reinfused into the patient with cancer. ACT using autologous ...